[Radiotherapy of carcinoma of the nasopharynz: clinical results (author's transl)].
A series of 64 patients with malignant tumours of the nasopharynx treated by cobalt irradiation is analyzed. The crude 5-year survival rate for the entire epithelial group was 32%; 55% for N- group, 25% for N+. Treatment methods avoiding complications are discussed.
D000230:Adenocarcinoma / Q000401:mortality / Q000532:radiotherapy; D000328:Adult; D000368:Aged; D003528:Carcinoma, Adenoid Cystic / Q000401:mortality / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000532:radiotherapy; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008223:Lymphoma / Q000401:mortality / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage
D003037:Cobalt Radioisotopes
Radioterapia dei carcinomi rinofaringei: risultati clinici.